K. Yu. Melnikov-Makarchuk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
K. Yu. Melnikov-Makarchuk has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Evgenievich Tyagunov
Pirogov Russian National Research Medical University
4 shared publications - Alexander Vyacheslavovich Sazhin
Pirogov Russian National Research Medical University
3 shared publications - Taras V. Nechay
Pirogov Russian National Research Medical University
3 shared publications - A.G. Yuldashev
Pirogov Russian National Research Medical University
2 shared publications - A. A. Tyagunov
Pirogov Russian National Research Medical University
1 shared publication - A. K. Bogomolova
Pirogov Russian National Research Medical University
1 shared publication
Latest Publications
- 13 November 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 11
Immediate and long-term results of surgical and conservative treatment of colonic diverticulitis WSES stage 0—2b
Objective. To compare the results of surgical and conservative treatment of patients with acute colon diverticulitis WSES grade 0—2b. Material and methods. A retrospective analysis of prospectively recruited groups included patients treated in the same hospital between 01.09.2014 and 01.02.2022 for acute colon diverticulitis WSES grade 0—2b. In therapeutic group, antibacterial and anti-inflammatory therapy was performed according to standard scheme. In surgical group, resection and debridement were performed via laparoscopic, open or robot-assisted access. Blood loss, surgery time and conversions were assessed in surgical group. In therapeutic group, we evaluated the number of patients who required surgical intervention. In both groups, length of hospital stay and complications according to the Clavien—Dindo classification were assessed. One year after discharge, a telephone survey was conducted to assess the incidence and severity of recurrence, as well as to evaluate the quality of life and health status using the EQ-5D-3L questionnaire. In both groups, complications were assessed using the Clavien—Dindo classification. Results. A total of 94 patients were included: 51 (54.3%) in therapeutic group and 43 (45.7%) ones in surgical group (8 [18.6%] with robot-assisted access, 13 [30.2%] with laparoscopy and 22 [51.2%] with laparotomy). There were significant between-group differences (p < 0.001) in severity of diverticulitis (WSES 0—1a in conservative group, WSES 0—2b in surgical group). However, both groups did not differ significantly in demographic characteristics, localization of inflammatory process, number of diverticulitis episodes, severity of inflammatory response or comorbidity. Resection and primary anastomosis were performed in 35 out of 43 (81.4%) patients in surgical group. Complications requiring repeated surgical or endoscopic interventions (Clavien—Dindo ≥ III) occurred in 5 out of 43 (11.6%) postoperative patients. The mortality rate was 2.3%. In therapeutic group, therapy was effective in 50 out of 51 (98.0%) patients; one patient required surgery due to persistent symptoms. The median length of hospital stay was 8 (6—9) days in surgical group and 3 (2.5—4) days in therapeutic group (p ≤ 0.001). Follow-up and telephone survey data on recurrence were obtained from 83 out of 94 (88.3%) patients, and 75 agreed to complete the quality of life questionnaire. Recurrence occurred in 13 out of 46 (28.3%) patients after therapeutic treatment and in 4 out of 37 (10.8%) after surgery (p=0.092). Four out of 17 (23.5%) patients with recurrence underwent surgery throughout the follow-up period (all from therapeutic group). There were no significant between-group differences in quality of life (EQ-5D-3L). Conclusion. Therapeutic treatment of diverticulitis WSES stages 0—2b is highly effective but associated with high recurrence rate. Every third patient with recurrence subsequently undergoes surgical treatment. Surgical treatment of diverticulitis exacerbations may reduce the risk of recurrence. However, it carries the risk of serious postoperative complications and does not significantly influence the quality of life.
- 13 November 2026
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 11
Immediate and long-term results of surgical and conservative treatment of colonic diverticulitis WSES stage 0—2b
Objective. To compare the results of surgical and conservative treatment of patients with acute colon diverticulitis WSES grade 0—2b. Material and methods. A retrospective analysis of prospectively recruited groups included patients treated in the same hospital between 01.09.2014 and 01.02.2022 for acute colon diverticulitis WSES grade 0—2b. In therapeutic group, antibacterial and anti-inflammatory therapy was performed according to standard scheme. In surgical group, resection and debridement were performed via laparoscopic, open or robot-assisted access. Blood loss, surgery time and conversions were assessed in surgical group. In therapeutic group, we evaluated the number of patients who required surgical intervention. In both groups, length of hospital stay and complications according to the Clavien—Dindo classification were assessed. One year after discharge, a telephone survey was conducted to assess the incidence and severity of recurrence, as well as to evaluate the quality of life and health status using the EQ-5D-3L questionnaire. In both groups, complications were assessed using the Clavien—Dindo classification. Results. A total of 94 patients were included: 51 (54.3%) in therapeutic group and 43 (45.7%) ones in surgical group (8 [18.6%] with robot-assisted access, 13 [30.2%] with laparoscopy and 22 [51.2%] with laparotomy). There were significant between-group differences (p < 0.001) in severity of diverticulitis (WSES 0—1a in conservative group, WSES 0—2b in surgical group). However, both groups did not differ significantly in demographic characteristics, localization of inflammatory process, number of diverticulitis episodes, severity of inflammatory response or comorbidity. Resection and primary anastomosis were performed in 35 out of 43 (81.4%) patients in surgical group. Complications requiring repeated surgical or endoscopic interventions (Clavien—Dindo ≥ III) occurred in 5 out of 43 (11.6%) postoperative patients. The mortality rate was 2.3%. In therapeutic group, therapy was effective in 50 out of 51 (98.0%) patients; one patient required surgery due to persistent symptoms. The median length of hospital stay was 8 (6—9) days in surgical group and 3 (2.5—4) days in therapeutic group (p ≤ 0.001). Follow-up and telephone survey data on recurrence were obtained from 83 out of 94 (88.3%) patients, and 75 agreed to complete the quality of life questionnaire. Recurrence occurred in 13 out of 46 (28.3%) patients after therapeutic treatment and in 4 out of 37 (10.8%) after surgery (p=0.092). Four out of 17 (23.5%) patients with recurrence underwent surgery throughout the follow-up period (all from therapeutic group). There were no significant between-group differences in quality of life (EQ-5D-3L). Conclusion. Therapeutic treatment of diverticulitis WSES stages 0—2b is highly effective but associated with high recurrence rate. Every third patient with recurrence subsequently undergoes surgical treatment. Surgical treatment of diverticulitis exacerbations may reduce the risk of recurrence. However, it carries the risk of serious postoperative complications and does not significantly influence the quality of life.
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Early surgery for strangulated and non-strangulated small bowel obstruction has no advantages over delayed procedure, especially in elderly patients: results of a multicenter retrospective cohort study
Background: Adhesive small bowel obstruction (SBO) can be managed surgically or non-operatively. However, there are still no well-established criteria for defining the optimal treatment strategy. Recent evidence suggests that early intervention within 24 hours of admission to hospital may benefit patients. Methods: This was a multicenter retrospective study of adhesive SBO investigating the outcomes of early surgery (75 years) with non-strangulated SBO (p=0.01). Conclusions: The surgery performed in the first 12 hours of admission, whether for strangulated or non-strangulated adhesive SBO, did not show advantages over delayed surgery. A less aggressive approach to the treatment of older or frail patients would be a wiser option.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 39
Open AccessEarly surgery for strangulated and non-strangulated small bowel obstruction has no advantages over delayed procedure, especially in elderly patients: results of a multicenter retrospective cohort study
Background: Adhesive small bowel obstruction (SBO) can be managed surgically or non-operatively. However, there are still no well-established criteria for defining the optimal treatment strategy. Recent evidence suggests that early intervention within 24 hours of admission to hospital may benefit patients. Methods: This was a multicenter retrospective study of adhesive SBO investigating the outcomes of early surgery (75 years) with non-strangulated SBO (p=0.01). Conclusions: The surgery performed in the first 12 hours of admission, whether for strangulated or non-strangulated adhesive SBO, did not show advantages over delayed surgery. A less aggressive approach to the treatment of older or frail patients would be a wiser option.
- 25 November 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 11,p. 7-25
Acute benign small bowel obstruction. Clinical guidelines
Acute benign small bowel obstruction. Clinical guidelines.
- 25 November 2025
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 11,p. 7-25
Acute benign small bowel obstruction. Clinical guidelines
Acute benign small bowel obstruction. Clinical guidelines.
- 23 January 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 42-49
Is vTAPP for small ventral hernias a potential «gold standard» for less than 24 hours hospitalization?
OBJECTIVE To evaluate clinical efficacy and cost-effectiveness of vTAPP for small/M3W1 hernias compared to IPOM. MATERIAL AND METHODS We retrospectively analyzed a prospectively recruited group of patients. Study objects were patients undergoing ventral laparoscopic transabdominal preperitoneal hernia repair (vTAPP) for primary Midline/Lateral Small hernias up to 2 cm. The control group comprised patients after IPOM procedure. RESULTS We analyzed 179 patients: vTAPP (n=132) and IPOM groups (n=47). The vTAPP group was characterized by significantly shorter hospitals-stay (Q1—Q3: 8—70 hours, pn=2, p=0.047) and slightly longer surgery (Q1—Q3: 40—80 min, p=0.037). Cost-effectiveness analysis revealed 3.39 times more profitable vTAPP compared to IPOM. CONCLUSION Laparoscopic preperitoneal hernia repair is a safe and effective method not requiring special tools and consumables. This approach is applicable as an outpatient (or <24h hospital-stay) method.
- 23 January 2024
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 1,p. 42-49
Is vTAPP for small ventral hernias a potential «gold standard» for less than 24 hours hospitalization?
OBJECTIVE To evaluate clinical efficacy and cost-effectiveness of vTAPP for small/M3W1 hernias compared to IPOM. MATERIAL AND METHODS We retrospectively analyzed a prospectively recruited group of patients. Study objects were patients undergoing ventral laparoscopic transabdominal preperitoneal hernia repair (vTAPP) for primary Midline/Lateral Small hernias up to 2 cm. The control group comprised patients after IPOM procedure. RESULTS We analyzed 179 patients: vTAPP (n=132) and IPOM groups (n=47). The vTAPP group was characterized by significantly shorter hospitals-stay (Q1—Q3: 8—70 hours, pn=2, p=0.047) and slightly longer surgery (Q1—Q3: 40—80 min, p=0.037). Cost-effectiveness analysis revealed 3.39 times more profitable vTAPP compared to IPOM. CONCLUSION Laparoscopic preperitoneal hernia repair is a safe and effective method not requiring special tools and consumables. This approach is applicable as an outpatient (or <24h hospital-stay) method.
- Open Access
- 14 June 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (2) , 30-40-40
Assessing and reducing severity of perioperative stress response to emergency surgery in patients with acute cholecystitis
Возможности оценки и уменьшения выраженности периоперационной стрессовой реакции в экстренной хирургии у больных острым холециститом
- 14 June 2023
- Published by Annals of Surgical Hepatology in Annaly khirurgicheskoy gepatologii = Annals of HPB surgery
- Vol. 28 (2) , 30-40-40
Open AccessAssessing and reducing severity of perioperative stress response to emergency surgery in patients with acute cholecystitis
Возможности оценки и уменьшения выраженности периоперационной стрессовой реакции в экстренной хирургии у больных острым холециститом
- 1 January 2022
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 88-101
Comparison of robot-assisted and conventional endoscopic surgeries in the Russian Federation. (A systematic review and meta-analysis)
ЦЕЛЬ РАБОТЫ Сравнительная оценка непосредственных и отдаленных результатов применения робот-ассистированных и традиционных видеоэндоскопических технологий в РФ с точки зрения доказательной медицины. МАТЕРИАЛ И МЕТОДЫ Поиск первоисточников с результатами робот-ассистированных (РАЭ) и традиционных видеоэндоскопических (ТВЭ) операций в РФ проведен в электронной библиотеке eLibrary и Кокрейновской базе данных CENTRAL. В работе использованы рекомендации ФГБУ «ЦЭККМП» Минздрава России (2017, 2019) и текущая версия руководства Кокрейновского сообщества (2021), в которой определены особенности метаанализа нерандомизированных сравнительных исследований. Для статистических расчетов использовано программное обеспечение Review Manager 5.4. РЕЗУЛЬТАТЫ В ходе систематического обзора отобраны 26 российских первоисточников с суммарной выборкой 3111 пациентов, среди которых 1174 (38%) пациента составили группу РАЭ-операций, 1937 (62%) — ТВЭ-операций. При этом рандомизированных контролируемых исследований в РФ не проводили и все первичные исследования являются сравнительными нерандомизированными. При обобщении результатов доказательной базы по РФ не выявлено статистически значимых различий между РАЭ- и ТВЭ-вмешательствами по таким параметрам сравнения, как длительность операции, частота интраоперационных осложнений, интраоперационной кровопотери в торакальной хирургии, урологии и гинекологии, вероятность конверсии, продолжительность послеоперационного лечения в стационаре, количество послеоперационных осложнений (в абдоминальной хирургии, урологии и гинекологии), уровень послеоперационной летальности. Отмечены тенденции меньшей интраоперационной кровопотери в ходе РАЭ-операций в абдоминальной хирургии и меньшей частоты послеоперационных осложнений в робот-ассистированной торакальной хирургии. Полученные результаты могут быть скомпрометированы методологическим качеством проводимых сравнительных исследований, высоким уровнем гетерогенности и систематических ошибок. ЗАКЛЮЧЕНИЕ В текущий момент развития хирургической практики в РФ нельзя достоверно судить о преимуществах использования робот-ассистированных технологий, поскольку установлено, что они не ухудшают и не улучшают результаты лечения больных. Необходимо проведение дальнейших исследований на более высоком уровне доказательности.
- 1 January 2022
- Published by Media Sphere Publishing Group in Pirogov Russian Journal of Surgery
- No. 6,p. 88-101
Comparison of robot-assisted and conventional endoscopic surgeries in the Russian Federation. (A systematic review and meta-analysis)
ЦЕЛЬ РАБОТЫ Сравнительная оценка непосредственных и отдаленных результатов применения робот-ассистированных и традиционных видеоэндоскопических технологий в РФ с точки зрения доказательной медицины. МАТЕРИАЛ И МЕТОДЫ Поиск первоисточников с результатами робот-ассистированных (РАЭ) и традиционных видеоэндоскопических (ТВЭ) операций в РФ проведен в электронной библиотеке eLibrary и Кокрейновской базе данных CENTRAL. В работе использованы рекомендации ФГБУ «ЦЭККМП» Минздрава России (2017, 2019) и текущая версия руководства Кокрейновского сообщества (2021), в которой определены особенности метаанализа нерандомизированных сравнительных исследований. Для статистических расчетов использовано программное обеспечение Review Manager 5.4. РЕЗУЛЬТАТЫ В ходе систематического обзора отобраны 26 российских первоисточников с суммарной выборкой 3111 пациентов, среди которых 1174 (38%) пациента составили группу РАЭ-операций, 1937 (62%) — ТВЭ-операций. При этом рандомизированных контролируемых исследований в РФ не проводили и все первичные исследования являются сравнительными нерандомизированными. При обобщении результатов доказательной базы по РФ не выявлено статистически значимых различий между РАЭ- и ТВЭ-вмешательствами по таким параметрам сравнения, как длительность операции, частота интраоперационных осложнений, интраоперационной кровопотери в торакальной хирургии, урологии и гинекологии, вероятность конверсии, продолжительность послеоперационного лечения в стационаре, количество послеоперационных осложнений (в абдоминальной хирургии, урологии и гинекологии), уровень послеоперационной летальности. Отмечены тенденции меньшей интраоперационной кровопотери в ходе РАЭ-операций в абдоминальной хирургии и меньшей частоты послеоперационных осложнений в робот-ассистированной торакальной хирургии. Полученные результаты могут быть скомпрометированы методологическим качеством проводимых сравнительных исследований, высоким уровнем гетерогенности и систематических ошибок. ЗАКЛЮЧЕНИЕ В текущий момент развития хирургической практики в РФ нельзя достоверно судить о преимуществах использования робот-ассистированных технологий, поскольку установлено, что они не ухудшают и не улучшают результаты лечения больных. Необходимо проведение дальнейших исследований на более высоком уровне доказательности.